Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T â„¢) products for cancer and autoimmune disease, today ...
Some results have been hidden because they may be inaccessible to you